Disposition pursuant to a tender of shares in a change of control transaction by Kenneth Moch of Zynerba Pharmaceuticals
| ZYNEDelisted Stock | USD 0.36 0.01 2.70% |
About 62% of Zynerba Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Zynerba Pharmaceuticals suggests that many traders are alarmed regarding Zynerba Pharmaceuticals' prospects. The current market sentiment, together with Zynerba Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Zynerba Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Zynerba |
Filed transaction by Zynerba Pharmaceuticals I director. Disposition pursuant to a tender of shares in a change of control transaction
Read at macroaxis.com
Zynerba Pharmaceuticals Fundamental Analysis
We analyze Zynerba Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zynerba Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zynerba Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Zynerba Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Zynerba Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zynerba Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Zynerba Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Zynerba Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Zynerba Pharmaceuticals Related Equities
| CLVR | Clever Leaves | 999,900 | ||||
| FLGC | Flora Growth | 10.83 | ||||
| IMCC | Im Cannabis | 8.13 | ||||
| TKNO | Alpha Teknova | 1.63 | ||||
| EBS | Emergent Biosolutions | 0.1 | ||||
| COLL | Collegium Pharmaceutical | 0.68 | ||||
| PAHC | Phibro Animal | 0.93 | ||||
| ITCI | Intracellular | 1.09 | ||||
| SXTC | China SXT | 2.44 | ||||
| DRRX | Durect | 3.30 | ||||
| BFRI | Biofrontera | 9.09 |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Zynerba Stock
If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |